Literature DB >> 35082389

Comment on: 'Incidence of chorioretinitis and endophthalmitis in hospitalized patients with fungemia'.

Mark P Breazzano1.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35082389      PMCID: PMC9391362          DOI: 10.1038/s41433-021-01905-3

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   4.456


× No keyword cloud information.
  5 in total

1.  Utility of Ophthalmologic Screening for Patients With Candida Bloodstream Infections: A Systematic Review.

Authors:  Mark P Breazzano; H Russell Day; Karen C Bloch; Sarah Tanaka; Edward F Cherney; Paul Sternberg; Sean P Donahue; John B Bond
Journal:  JAMA Ophthalmol       Date:  2019-06-01       Impact factor: 7.389

Review 2.  Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2016-02-15       Impact factor: 9.079

Review 3.  Retinal lesions as clues to disseminated bacterial and candidal infections: frequency, natural history, and etiology.

Authors:  Libsen J Rodríguez-Adrián; Robert T King; Luis G Tamayo-Derat; John W Miller; Charles A Garcia; John H Rex
Journal:  Medicine (Baltimore)       Date:  2003-05       Impact factor: 1.889

4.  American Academy of Ophthalmology Recommendations on Screening for Endogenous Candida Endophthalmitis.

Authors:  Mark P Breazzano; John B Bond; Srilaxmi Bearelly; Donna H Kim; Sean P Donahue; Flora Lum; Timothy W Olsen
Journal:  Ophthalmology       Date:  2021-07-19       Impact factor: 12.079

5.  Incidence of chorioretinitis and endophthalmitis in hospitalized patients with fungemia.

Authors:  Mohammad Z Siddiqui; Grant M Gebhard; Kinza T Ahmad; Ahmed B Sallam; Eric R Rosenbaum; Sami H Uwaydat
Journal:  Eye (Lond)       Date:  2021-03-08       Impact factor: 3.775

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.